Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| APS | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 407.0 | Evidence | |||||
| APS | CSK | CSK: Tyrosine-protein kinase CSK | 268.0 | Evidence | |||||
| APS | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence |
|
||||
| APS | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 200.0 | Evidence |
|
||||
| APS | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 198.0 | Evidence |
|
||||
| APS | LYN | LYN: Tyrosine-protein kinase Lyn | 180.0 | Evidence |
|
||||
| APS | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 176.0 | Evidence | |||||
| APS | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 162.0 | Evidence | |||||
| APS | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 161.0 | Evidence | |||||
| APS | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 149.0 | Evidence | |||||
| APS | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 149.0 | Evidence | |||||
| APS | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 137.0 | Evidence | |||||
| APS | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 134.0 | Evidence | |||||
| APS | KIT | KIT: Mast/stem cell growth factor receptor precursor | 132.0 | Evidence |
|
||||
| APS | SYK | SYK: Tyrosine-protein kinase SYK | 128.0 | Evidence |
|
||||
| APS | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 119.0 | Evidence | |||||
| APS | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| APS | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 106.0 | Evidence | |||||
| APS | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 88.80 | Evidence | |||||
| APS | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 88.80 | Evidence | |||||
| APS | BMX | N/A | 88.80 | Evidence | |||||
| APS | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 80.00 | Evidence | |||||
| APS | INSR | INSR: Insulin receptor precursor | 80.00 | Evidence |
|
||||
| APS | HCK | N/A | 79.50 | Evidence | |||||
| APS | JAK1 | 79.50 | Evidence |
|
|||||
| APS | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 79.40 | Evidence | |||||
| APS | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 73.60 | Evidence | |||||
| APS | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 52.80 | Evidence | |||||
| APS | NCK2 | NCK2: Cytoplasmic protein NCK2 | 39.10 | Evidence | |||||
| APS | CRKL | CRKL: Crk-like protein | 31.20 | Evidence | |||||
| APS | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 25.90 | Evidence | |||||
| APS | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 25.3 | Evidence | |||||
| APS | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 25.3 | Evidence | |||||
| APS | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 24.90 | Evidence | |||||
| APS | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 22.80 | Evidence | |||||
| APS | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 22.30 | Evidence | |||||
| APS | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 20.50 | Evidence | |||||
| APS | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 20.50 | Evidence | |||||
| APS | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 20.50 | Evidence |
|
||||
| APS | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 20.40 | Evidence | |||||
| APS | STAT3 | 19.70 | Evidence | ||||||
| APS | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 18.90 | Evidence | |||||
| APS | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 17.30 | Evidence | |||||
| APS | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 16.20 | Evidence | |||||
| APS | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 15.50 | Evidence | |||||
| APS | VAV1 | VAV1, VAV: Proto-oncogene vav | 15.50 | Evidence | |||||
| APS | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 15.50 | Evidence | |||||
| APS | STAM2 | STAM2: Signal transducing adapter molecule 2 | 15.30 | Evidence | |||||
| APS | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence | |||||
| APS | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.00 | Evidence | |||||
| APS | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 13.80 | Evidence | |||||
| APS | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 13.50 | Evidence | |||||
| APS | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 13.40 | Evidence | |||||
| APS | DOK1 | DOK1: Docking protein 1 | 12.40 | Evidence | |||||
| APS | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 12.40 | Evidence | |||||
| APS | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 11.40 | Evidence | |||||
| APS | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 11.40 | Evidence | |||||
| APS | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 11.20 | Evidence | |||||
| APS | IRS1 | IRS1: Insulin receptor substrate 1 | 11.20 | Evidence | |||||
| APS | SOS1 | SOS1: Son of sevenless homolog 1 | 10.70 | Evidence | |||||
| APS | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 10.70 | Evidence | |||||
| APS | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 10.10 | Evidence |
|
||||
| APS | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 10.00 | Evidence | |||||
| APS | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 10.00 | Evidence | |||||
| APS | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
| APS | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
| APS | IRS2 | IRS2: Insulin receptor substrate 2 | 9.89 | Evidence | |||||
| APS | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 9.14 | Evidence | |||||
| APS | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 9.14 | Evidence | |||||
| APS | CTTN | CTTN, EMS1: Src substrate cortactin | 8.92 | Evidence | |||||
| APS | CREBBP | CREBBP, CBP: CREB-binding protein | 8.00 | Evidence | |||||
| APS | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 7.85 | Evidence | |||||
| APS | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 7.59 | Evidence | |||||
| APS | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 7.40 | Evidence | |||||
| APS | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 6.78 | Evidence | |||||
| APS | ITGB4 | N/A | 6.52 | Evidence | |||||
| APS | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 6.52 | Evidence | |||||
| APS | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 6.52 | Evidence | |||||
| APS | GRAP | GRAP: GRB2-related adapter protein | 6.31 | Evidence | |||||
| APS | EPOR | EPOR: Erythropoietin receptor precursor | 5.88 | Evidence |
|
||||
| APS | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
| APS | DAPP1 | N/A | 4.73 | Evidence | |||||
| APS | KIRREL | KIRREL, KIRREL1, NEPH1: Kin of IRRE-like protein 1 precursor | 4.68 | Evidence | |||||
| APS | DNM1 | DNM1, DNM: Dynamin-1 | 4.68 | Evidence | |||||
| APS | GRB10 | N/A | 4.68 | Evidence | |||||
| APS | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 4.31 | Evidence | |||||
| APS | CD19 | N/A | 4.06 | Evidence | |||||
| APS | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.93 | Evidence | |||||
| APS | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 3.49 | Evidence | |||||
| APS | CASP3 | CASP3, CPP32: Caspase-3 precursor | 2.63 | Evidence | |||||